SEC Company Response from Enveric Biosciences, Inc. (ENVB) (CIK 0000890821) (ENVB) — Nov 12, 2019
Enveric Biosciences, Inc. (ENVB) (CIK 0000890821)
Date: Nov. 12, 2019 · CIK: 0000890821 · Accession: 0001140361-19-020291
AI Filing Summary & Sentiment
File numbers found in text: 333-233260
Show Raw Text
CORRESP
1
filename1.htm
AMERI Holdings, Inc.
5000 Research Court, Suite 750,
Suwanee, Georgia, 30024
November 12, 2019
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Heather Percival
Re:
Ameri Holdings, Inc.
Registration Statement on Form S-3
File No. 333-233260
Ladies and Gentlemen:
Ameri Holdings, Inc. (the “Company”) hereby respectfully withdraws its request, dated November 8, 2019, that the effective date of the registration statement referred to above be accelerated so that it
will become effective at 5:00 p.m., Eastern Time, on Tuesday, November 12, 2019. The Company intends to submit a revised acceleration request at a later date.
Please notify Richard Friedman of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3031, if there are any questions with respect to this
request.
Respectfully,
Ameri Holdings, Inc.
By:
/s/ Barry Kostiner
Name:
Barry Kostiner
Title:
Chief Financial Officer
-1-